CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-25 | Manni Joseph S. Chief Revenue Officer | Shares withheld for taxes | −660 | $11.58 | $8K | 27,761 |
| 2025-08-25 | Woo Raymond Chief Technology Officer | Shares withheld for taxes | −687 | $11.58 | $8K | 147,704 |
| 2025-08-25 | Foehr David Senior VP, Finance and PAO | Shares withheld for taxes | −484 | $11.58 | $6K | 21,116 |
| 2025-08-25 | Blumberg Scott Chief Financial Officer | Shares withheld for taxes | −687 | $11.58 | $8K | 119,374 |
| 2025-08-25 | Chao Xingjuan President and CEO | Shares withheld for taxes | −2,887 | $11.58 | $33K | 773,135 |
| 2025-08-19 | Taylor Joseph Michael Director | Sale | −7,032 | $11.76 | $83K | 59,235 |
| 2025-07-07 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +25,000 | $2.24 | $56K | 801,222 |
| 2025-07-07 | Chao Xingjuan President and CEO | Sale 10b5-1 | −25,000 | $17.70 | $443K | 776,022 |
| 2025-07-07 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 52,551 | ||
| 2025-06-18 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −11,188 | $17.85 | $200K | 10,042 |
| 2025-06-17 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −7,445 | $17.63 | $131K | 21,230 |
| 2025-06-17 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −7,445 | $17.63 | $131K | 21,230 |
| 2025-06-16 | ROBERTSON REBECCA B Director | Option exercise 10b5-1 | +545 | $2.24 | $1K | 29,220 |
| 2025-06-16 | ROBERTSON REBECCA B Director | Option exercise 10b5-1 | +19,455 | $3.65 | $71K | 48,675 |
| 2025-06-16 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −20,000 | $17.14 | $343K | 28,675 |
| 2025-06-16 | ROBERTSON REBECCA B Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −545 | 15,150 | ||
| 2025-06-16 | ROBERTSON REBECCA B Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,455 | 0 | ||
| 2025-06-10 | ROBERTSON REBECCA B Director | Grant or award 10b5-1 | +8,828 | 28,675 | ||
| 2025-06-10 | Tammenoms Bakker Juliet Director | Grant or award | +8,828 | 15,446 | ||
| 2025-06-10 | Parvizi Josef Director | Grant or award | +8,828 | 822,652 |
Page 16 of 17 · 330 trades